貝因美(002570.SZ)一季度預盈1072萬-1572萬元
格隆匯 4 月 12日丨貝因美(002570.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤1072萬元-1572萬元,上年同期盈利1295.37萬元;扣除非經常性損益後的淨利潤200萬元-700萬元,同比增長87.88%-557.59%。
報吿期內,公司克服後疫情等帶來的不利影響,化危為機,不斷改善內部運營,狠抓精準營銷。同時,公司進一步加強管理,降本增效,加速庫存週轉,取得了明顯成效,扣除非經常性損益後的淨利潤較上年同期有明顯提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.